Free Trial

Benitec Biopharma (BNTC) Earnings Date, Estimates & Call Transcripts

Benitec Biopharma logo
$11.30 -0.27 (-2.33%)
Closing price 02/21/2025 04:00 PM Eastern
Extended Trading
$11.01 -0.29 (-2.60%)
As of 02/21/2025 07:15 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Benitec Biopharma Latest Earnings Summary

Upcoming Q3
Earnings Date
May. 12Estimated
Actual EPS
(Feb. 14)
-$0.36 Beat By $0.19
Consensus EPS
(Feb. 14)
-$0.55

Benitec Biopharma released Q2 2025 earnings on February 14, 2025, reporting an EPS of -$0.36, which beat the consensus estimate of -$0.55 by $0.19. With a trailing EPS of $0.00, Benitec Biopharma's earnings are expected to decrease next year, from ($1.48) to ($2.31) per share.

BNTC Upcoming Earnings

Benitec Biopharma's next earnings date is estimated for Monday, May 12, 2025, based off prior year's reporting schedules.

Get Benitec Biopharma Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Benitec Biopharma and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

BNTC Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

BNTC Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Benitec Biopharma Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20251-$0.54-$0.54-$0.54
Q2 20252-$0.34-$0.27-$0.31
Q3 20252-$0.34-$0.31-$0.33
Q4 20252-$0.35-$0.34-$0.35
FY 20257($1.57)($1.46)($1.52)

Benitec Biopharma Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/12/2025
(Estimated)
-------
2/14/2025Q2 2025-$0.55-$0.36+$0.19-$0.33--
5/13/2024Q3 2024--$1.64 -$1.64-$1.64--
2/13/2024Q2 2024--$2.64 -$2.64-$2.64--
11/13/2023Q1 2024--$2.76 -$2.76-$2.76--
5/15/2023Q3 2023--$2.72 -$2.72-$0.16-$0.05M

Benitec Biopharma Earnings - Frequently Asked Questions

Benitec Biopharma has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 12th, 2025 based off last year's report dates. Learn more on BNTC's earnings history.

In the previous quarter, Benitec Biopharma (NASDAQ:BNTC) reported ($0.36) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.55) by $0.19. Learn more on analysts' earnings estimate vs. BNTC's actual earnings.

Benitec Biopharma (NASDAQ:BNTC) has a recorded annual revenue of $80,000.00.

Benitec Biopharma (NASDAQ:BNTC) has a recorded net income of -$21.75 million. BNTC has generated $0.00 earnings per share over the last four quarters.

Benitec Biopharma's earnings are expected to decrease from ($1.48) per share to ($2.31) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:BNTC) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners